VERTEX PHARMACEUTICALS INC's ticker is and the CUSIP is 92532F900. A total of 8 filers reported holding VERTEX PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,850,478 | +104.9% | 19,700 | +107.4% | 0.01% | +100.0% |
| Q2 2023 | $3,343,145 | +34.3% | 9,500 | +20.3% | 0.01% | +50.0% |
| Q1 2023 | $2,489,053 | +95.9% | 7,900 | +79.5% | 0.00% | +100.0% |
| Q4 2022 | $1,270,632 | +109.0% | 4,400 | +109.5% | 0.00% | +100.0% |
| Q3 2022 | $608,000 | +96.1% | 2,100 | +90.9% | 0.00% | – |
| Q2 2022 | $310,000 | +48.3% | 1,100 | +37.5% | 0.00% | – |
| Q1 2022 | $209,000 | -72.6% | 800 | -81.0% | 0.00% | -100.0% |
| Q3 2021 | $762,000 | -0.5% | 4,200 | +10.5% | 0.00% | 0.0% |
| Q2 2021 | $766,000 | -49.3% | 3,800 | -26.9% | 0.00% | -50.0% |
| Q2 2020 | $1,510,000 | -56.2% | 5,200 | -64.1% | 0.00% | -60.0% |
| Q1 2020 | $3,450,000 | -25.7% | 14,500 | -31.6% | 0.01% | +25.0% |
| Q4 2019 | $4,642,000 | +18.1% | 21,200 | -8.6% | 0.00% | 0.0% |
| Q3 2019 | $3,931,000 | +6.1% | 23,200 | +14.9% | 0.00% | +33.3% |
| Q2 2019 | $3,704,000 | +136.8% | 20,200 | +137.6% | 0.00% | +50.0% |
| Q1 2019 | $1,564,000 | +293.0% | 8,500 | +254.2% | 0.00% | – |
| Q4 2018 | $398,000 | -47.1% | 2,400 | -38.5% | 0.00% | -100.0% |
| Q3 2018 | $752,000 | +13.4% | 3,900 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $663,000 | +4.2% | 3,900 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $636,000 | -90.2% | 3,900 | -91.0% | 0.00% | -80.0% |
| Q4 2017 | $6,459,000 | +0.9% | 43,100 | +2.4% | 0.01% | -16.7% |
| Q3 2017 | $6,401,000 | +54.2% | 42,100 | +30.7% | 0.01% | +50.0% |
| Q2 2017 | $4,150,000 | +26.1% | 32,200 | +7.0% | 0.00% | +33.3% |
| Q1 2017 | $3,291,000 | +4.6% | 30,100 | -29.5% | 0.00% | 0.0% |
| Q4 2016 | $3,146,000 | +32.6% | 42,700 | +57.0% | 0.00% | +50.0% |
| Q3 2016 | $2,372,000 | +11.6% | 27,200 | +10.1% | 0.00% | 0.0% |
| Q2 2016 | $2,125,000 | +225.9% | 24,700 | +201.2% | 0.00% | +100.0% |
| Q1 2016 | $652,000 | -26.0% | 8,200 | +17.1% | 0.00% | 0.0% |
| Q4 2015 | $881,000 | +96.7% | 7,000 | +62.8% | 0.00% | 0.0% |
| Q3 2015 | $448,000 | -48.9% | 4,300 | -39.4% | 0.00% | 0.0% |
| Q2 2015 | $877,000 | +69.0% | 7,100 | +61.4% | 0.00% | 0.0% |
| Q1 2015 | $519,000 | – | 4,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 99,400 | $34,565,356 | 0.12% |
| SIMPLEX TRADING, LLC | 61,500 | $21,386 | 0.02% |
| IMC-Chicago, LLC | 47,900 | $16,656,746 | 0.02% |
| JANE STREET GROUP, LLC | 119,000 | $41,381,060 | 0.01% |
| Allianz Asset Management GmbH | 19,700 | $6,850,478 | 0.01% |
| SG Americas Securities, LLC | 59,600 | $593 | 0.01% |
| Maven Securities LTD | 900 | $312,966 | 0.00% |
| JPMORGAN CHASE & CO | 40,500 | $14,083,470 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| OSAIC HOLDINGS, INC. | 1 | $5,420 | 0.00% |